Clinical Trials Directory

Trials / Completed

CompletedNCT06376409

Prospective Study of Nutraceutical Supplements to Support Hair Growth in Females

A Single-center, Prospective Study of Nutraceutical Supplements to Support Hair Growth in Females With Self-Perceived Thinning Hair

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
181 (actual)
Sponsor
Nutraceutical Wellness Inc. · Industry
Sex
Female
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

A single site open label interventional study evaluating currently marketed hair supplements targeting the underlying root causes of thinning hair.

Detailed description

A single site open label interventional study evaluating currently marketed hair supplements targeting the underlying root causes of thinning hair. All treatment regimens are commercially available nutraceutical hair growth supplements. 45 subjects will be enrolled into each of the 4 supplement groups. Subjects will undergo a baseline, baseline + 48 hours, 90 day, 90 day + 48 hours, 180 day and 180 day + 48 hours visit and will have compliance phone calls at Days 45 and 135. All subject data will be compared to baseline in paired comparison for each subject using a historical control.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTNutrafol Women's Hair Growth SupplementHair growth supplement for women ages 18 - 44
DIETARY_SUPPLEMENTNutrafol Women's Balance Hair Growth SupplementHair growth supplement for women ages 45 - 70
DIETARY_SUPPLEMENTNutrafol Women's Vegan Hair Growth SupplementHair growth supplement for women ages 18 - 44. This treatment group may also include subjects who do not follow a plant-based diet for purposes of extending the product claims beyond the initially studied demographic of women primarily adhering to a plant-based diet
DIETARY_SUPPLEMENTNutrafol Women's Postpartum Hair Growth SupplementHair growth supplement for women ages 18 - 44. This product will be studied in the general women population and not postpartum women.

Timeline

Start date
2024-05-06
Primary completion
2025-06-18
Completion
2025-06-18
First posted
2024-04-19
Last updated
2025-07-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06376409. Inclusion in this directory is not an endorsement.